Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors
Patrícia M. R. Pereira(Memorial Sloan Kettering Cancer Center), Jason S. Lewis(Memorial Sloan Kettering Cancer Center)
Cited by 32
Related Papers
1-<sup>11</sup>C-Acetate as a PET Radiopharmaceutical for Imaging Fatty Acid Synthase Expression in Prostate Cancer
|Journal of Nuclear Medicine|2008|154
Measuring the Pharmacodynamic Effects of a Novel Hsp90 Inhibitor on HER2/neu Expression in Mice Using 89Zr-DFO-Trastuzumab
|PLoS ONE|2010|129
Monitoring Afatinib Treatment in HER2-Positive Gastric Cancer with <sup>18</sup>F-FDG and <sup>89</sup>Zr-Trastuzumab PET
|Journal of Nuclear Medicine|2013|93
Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer
|Nature Communications|2022|40